Prospective, Interventional Pilot Study of Mobile Devices and Digital Applications to Detect Early Pneumonitis and Other Pulmonary Adverse Events Causing Treatment Discontinuations in Unresectable Stage III Non-Small Cell Lung Cancer Patients on Durvalumab

Brief Summary

Type:
Lung Cancers

Study Type:
Other

Phase:
Feasibility/Pilot

ClinicalTrials.gov Identifier:
NCT04381494

Study #:
STUDY00145017

Start Date:
Sep 27, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04381494

View Complete Trial Details & Eligibility at ClinicalTrials.gov